{"nct_id":"NCT04816643","title":"A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children","status":"COMPLETED","status_verified_date":"2023-12","start_date":"2021-03-24","start_date_type":"ACTUAL","primary_completion_date":"2023-10-04","primary_completion_date_type":"ACTUAL","completion_date":"2023-12-08","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["BNTX"]}